Medical Marijuana Qualifying Conditions by State

Qualifying conditions are the gateway to every state medical marijuana program — the specific diagnoses or symptoms a patient must have before a physician can legally recommend cannabis. Those lists vary significantly from state to state, which means a condition that qualifies in one state may not qualify in a neighboring one. This page maps the structural logic of how those lists are built, where the notable differences fall, and what the decision process looks like in practice.

Definition and Scope

A qualifying condition, in the medical marijuana context, is a diagnosis or clinical symptom category that a state legislature or health department has designated as eligible for cannabis-based treatment recommendations. The designation is a regulatory act, not a medical one — it reflects what lawmakers and appointed health officials have approved, which does not always align neatly with what clinical evidence supports or what the FDA has cleared.

As of 2024, 38 states plus the District of Columbia had enacted medical marijuana programs (NCSL, State Medical Marijuana Laws). Each operates its own qualifying conditions list under its own administrative code. The regulatory context for medical marijuana is therefore genuinely fragmented — there is no federal template, because cannabis remains a Schedule I controlled substance under the Controlled Substances Act (21 U.S.C. § 812), leaving states to construct their frameworks independently.

The scope of these lists ranges from narrow to sweeping. Virginia, for instance, moved to a broad practitioner-discretion model, while states like Idaho have no medical program at all. The practical consequence is that a patient with fibromyalgia qualifies in Michigan but would not qualify in states whose lists require a more specific diagnosis.

How It Works

State programs generally follow one of three structural models when building qualifying condition frameworks:

1. Enumerated list only — The statute names a fixed set of conditions (e.g., cancer, glaucoma, HIV/AIDS, epilepsy, PTSD). A patient must match one exactly. If the condition is not on the list, there is no pathway, regardless of clinical severity.

2. Enumerated list plus physician discretion — A core list is supplemented by a clause permitting licensed physicians to recommend cannabis for conditions of "similar severity" or for conditions not verified, subject to documented clinical judgment. California and Florida operate broadly under this type of hybrid model.

3. Practitioner-led, condition-agnostic — A small number of states have restructured their programs so that any licensed practitioner can certify a patient if cannabis is clinically appropriate, without requiring a specific diagnosis. Virginia's 2021 program revision moved substantially in this direction.

The state-by-state medical marijuana programs overview covers how individual state health departments administer these frameworks in practice. The certifying physician's role is the pivot point in every model — physicians do not prescribe cannabis (that remains federally prohibited), but they issue written certifications or recommendations that satisfy the state registry requirement.

Common Scenarios

Certain conditions appear on nearly every state qualifying list, forming something close to a national consensus. Cancer, epilepsy, multiple sclerosis, HIV/AIDS, and chronic pain appear across 35 or more state programs. Seizure disorders became nearly universal after the high-profile clinical attention around CBD and pediatric epilepsy, and the FDA's 2018 approval of Epidiolex — the first plant-derived cannabinoid medication cleared through the standard drug approval process — reinforced the clinical legitimacy of cannabis-based treatment in that category.

PTSD qualifies in roughly 30 states, a significant expansion from the early generation of programs that limited the list to terminal or physically debilitating conditions. Glaucoma was one of the original qualifying conditions when California passed Proposition 215 in 1996, though it now appears in fewer new-generation state programs — partly because modern pharmaceutical options for intraocular pressure have advanced, and partly because the duration of cannabis's effect on eye pressure (roughly 3 to 4 hours per dose, according to the American Academy of Ophthalmology) limits its clinical appeal relative to other treatments.

Conditions that appear on fewer than 15 state lists include autism spectrum disorder, Tourette syndrome, and post-laminectomy syndrome. These represent the contested middle tier — conditions where patient advocacy has outpaced the clinical consensus that state health departments require to add a diagnosis formally.

Decision Boundaries

The key distinction that determines whether a patient qualifies is not just which condition they have, but which model their state uses. Under an enumerated-only model, a diagnosis of fibromyalgia in a state that lists only "severe chronic pain" may or may not qualify — it depends on whether the certifying physician can document that the fibromyalgia meets the state's severity threshold and whether state health officials accept that framing.

Three structural boundaries are worth understanding clearly:

• Condition vs. symptom — Some states list the underlying diagnosis (e.g., Crohn's disease); others list the symptom category (e.g., severe nausea, cachexia). A patient with cancer-related nausea may qualify under a symptom-based list even if "cancer" itself is not enumerated separately.
• Severity requirements — Most states attach a qualifier: "debilitating," "intractable," or "severe." These terms are defined in administrative code, and definitions vary. Florida's administrative rule (FAC 64-4.002) specifies that the condition must be "of the same kind or class" as enumerated diagnoses.
• Pediatric vs. adult lists — 14 states maintain separate qualifying condition lists or additional approval requirements for patients under 18, typically restricting eligibility to severe seizure disorders or terminal illness unless a second physician concurs.

Finding a medical marijuana doctor who is familiar with a specific state's administrative interpretation of these categories matters more than most patients initially expect — the clinical record that a physician documents at the certification appointment must match the language the state registry uses to process the application. The medical marijuana card qualification process depends entirely on that alignment being precise.